These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 11642083

  • 1. [Neoton and thrombolytic therapy of myocardial infarction].
    Perepech NB, Nedoshivin AO, Nesterova IV.
    Ter Arkh; 2001; 73(9):50-5. PubMed ID: 11642083
    [Abstract] [Full Text] [Related]

  • 2. [Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction].
    Perepech NB, Nedoshivin AO, Kutuzova A'E.
    Klin Med (Mosk); 1997; 75(10):52-4. PubMed ID: 9490342
    [Abstract] [Full Text] [Related]

  • 3. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
    Tarasov NI, Kokov AN, Barbarash LS.
    Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
    [Abstract] [Full Text] [Related]

  • 4. [The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study].
    Stejfa M, Zeman K, Groch L, Marek J, Komárek J, Janota T, Vávra F, Kölbel F, Charvát I, Weinbergová O.
    Vnitr Lek; 1993 Feb; 39(2):136-42. PubMed ID: 8506660
    [Abstract] [Full Text] [Related]

  • 5. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
    Korotkov A, Kistauri A, Korotkova A, Jibladze M, Guchua E.
    Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
    [Abstract] [Full Text] [Related]

  • 6. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB, Nedoshivin AO, Kutuzova AE.
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [Abstract] [Full Text] [Related]

  • 7. [Effect of systemic thrombolytic therapy on clinico-hemodynamic indicators in patients with acute myocardial infarction].
    Perepech NB, Nedoshivin AO, Makedonov AL, Kutuzova AE.
    Klin Med (Mosk); 1991 Jan; 69(1):51-3. PubMed ID: 2023396
    [Abstract] [Full Text] [Related]

  • 8. [Systemic thrombolytic therapy in acute myocardial infarct: its effect on left ventricular function, body oxygen consumption and disease prognosis].
    Perepech NB, Nedoshivin AO, Kutuzova AE, Nesterova IV, Mikhaĭlova IE.
    Ter Arkh; 1993 Jan; 65(8):7-12. PubMed ID: 8211809
    [Abstract] [Full Text] [Related]

  • 9. Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction.
    Ruda MYa, Samarenko MB, Afonskaya NI, Saks VA.
    Am Heart J; 1988 Aug; 116(2 Pt 1):393-7. PubMed ID: 2456682
    [Abstract] [Full Text] [Related]

  • 10. [Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure].
    Nedoshivin AO, Perepech NB.
    Klin Med (Mosk); 1996 Aug; 74(9):45-8. PubMed ID: 9121090
    [Abstract] [Full Text] [Related]

  • 11. [Assessment of myocardial viability and recovery of the left ventricular function in postmyocardial infarction patients].
    Vaolutskene E, Ivashkiavichene L, Grabauskene V, Lautsavichus A.
    Ter Arkh; 2004 Aug; 76(12):12-7. PubMed ID: 15724918
    [Abstract] [Full Text] [Related]

  • 12. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M, Petrescu L, Riviş AI, Suşan RM, Burghină D, Dan R, Cozma D, Drăgulescu SI.
    Rom J Intern Med; 2005 Nov 29; 43(3-4):187-98. PubMed ID: 16812979
    [Abstract] [Full Text] [Related]

  • 15. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthøj S, Torp-Pedersen C, Køber L.
    Int J Cardiol; 2005 Sep 30; 104(2):184-9. PubMed ID: 16168812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA, Al Suwaidi J, Bener A, Khinji A, Al Binali HA.
    Int J Cardiol; 2005 Jul 10; 102(2):249-54. PubMed ID: 15982492
    [Abstract] [Full Text] [Related]

  • 18. Echocardiographic diastolic dysfunction and magnetic resonance infarct size in healed myocardial infarction treated with primary angioplasty.
    Barbieri A, Bursi F, Politi L, Rossi L, Fiocchi F, Ligabue G, Pingitore A, Positano V, Torricelli P, Modena MG.
    Echocardiography; 2008 Jul 10; 25(6):575-83. PubMed ID: 18422674
    [Abstract] [Full Text] [Related]

  • 19. [Trimetazidine effects on postinfarction remodeling of the left ventricle].
    Kokov AN, Tarasov II, Barbarash LS.
    Ter Arkh; 2005 Jul 10; 77(8):10-4. PubMed ID: 16206598
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG, Duong T, Bland JM, Malik M, Torp-Pederson C, Køber L, Connolly SJ, Gallagher MM, Camm AJ.
    J Hypertens; 2007 Feb 10; 25(2):307-13. PubMed ID: 17211237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.